Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity

Oncologist

Volumn 17, Issue 11, 2012, Pages 1386-1393

  Ben Aharon, Irit ^a,c   Meizner, Israel ^b,c   Granot, Tal ^a   Uri, Shiri ^c   Hasky, Noa ^c   Rizel, Shulamith ^a,c   Yerushalmi, Rinat ^a,c   Sulkes, Aaron ^a,c   Stemmer, Salomon M ^a,c  

^a Davidoff Center   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer disclosures: the authors indicated no financial relationships; Chemotherapy; Ovary; Premenopausal; Vascular toxicity

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; FOLLITROPIN; GONADORELIN AGONIST; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DOPPLER FLOWMETER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOT FLUSH; HUMAN; OVARY BLOOD FLOW; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SWEATING; TRANSVAGINAL ECHOGRAPHY; VAGINAL DRYNESS; VASCULAR DISEASE; VASCULAR RESISTANCE; VASCULARIZATION;

ADULT; AMENORRHEA; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BLOOD FLOW VELOCITY; BREAST NEOPLASMS; FEMALE; HUMANS; MENOPAUSE, PREMATURE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; REGIONAL BLOOD FLOW; TAXOIDS;

EID: 84869397883     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0172     Document Type: Article

References (28)

1. Swain SM, Jeong JH, Geyer CE Jretal. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N EnglJMed 2010;362:2053-2065.
2. Knobf MT. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. The Oncologist 2006;11:96-110.
3. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14: 1718-1729.
4. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006;24:5769-5779.
5. Petrek JA, Naughton MJ, Case LD et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 2006;24:1045-1051.
6. Oktay K, Oktem O, Reh A et al. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 2006;24:4044-4046.
7. Fornier MN, Modi S, Panageas KS et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005; 104:1575-1579.
8. Abusief ME, Missmer SA, Ginsburg ES et al. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women withbreast cancer. Cancer 2010;116:791-798.
9. Sukumvanich P, Case LD, Van Zee K et al. Incidence and time course ofbleeding after long-term amenorrhea after breast cancer treatment: A prospective study. Cancer 2010;116:3102-3111.
10. Bar-Joseph H, Ben-Aharon I, Tzabari M et al. In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels. PLoS One 2011;6:e23492.
11. Bissett D, Kunkeler L, Zwanenburg L et al. Longterm sequelae of treatment for testicular germ cell tumours. Br J Cancer 1990;62:655-659.
12. Berger CC, Bokemeyer C, Schneider M et al. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Eur J Cancer 1995;31A:2229-2238.
13. Nuver J, Smit AJ, van der Meer J. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 2005;23:9130-9137.
14. Chow AY, Chin C, Dahl G et al. Anthracyclines cause endothelial injury in pediatric cancer patients: A pilot study. J Clin Oncol 2006;24:925-928.
15. Nitzschke M, Raddatz J, Bohlmann MK et al. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients. Arch Gynecol Obstet 2010;282:83-88.
16. Van Beek RD, van den Heuvel-Eibrink MM, Laven JSetal. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007;92:3869-3874.
17. Bath LE, Wallace WH, Shaw MP et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368-2374.
18. Kelsey TW, Wright P, Nelson SM et al. A validated model of serum anti-Mullerian hormone from conception to menopause. PLoS One 2011;6:e22024.
19. Weenen C, Laven JS, Von Bergh AR et al. Anti-Mullerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.
20. Ben-Aharon I, Bar-Joseph H, Tzarfaty G et al. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol 2010;8:20.
21. Anderson RA, Themmen AP, Al-Qahtani A et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006;21: 2583-2592.
22. Gerber B, von Minckwitz G, Stehle H et al.; German Breast Group Investigators. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J Clin Oncol 2011;29:2334-2341.
23. King LJ, Hasnain SN, Webb JA et al. Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology 1999;213:167-172.
24. So NM, Lam WW, Chook P et al. Carotid intimamedia thickness in patients with head and neck irradiation for the treatment of nasopharyngeal carcinoma. Clin Radiol 2002;57:600-603.
25. Duquaine D, Hirsch GA, Chakrabarti A et al. Rap-id-onset endothelial dysfunction with adriamycin: Evidence for a dysfunctional nitric oxide synthase. Vasc Med 2003;8:101-107.
26. Chaosuwannakit N, D'Agostino R Jr, Hamilton CA et al. Aortic stiffness increases upon receipt of an-thracycline chemotherapy. J Clin Oncol 2010;28:166-172.
27. Partridge AH, Ruddy KJ, Gelber S et al Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010;94:638-644.
28. Ng EH, Chan CC, YeungWS et al. Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility. Hum Reprod 2004;19:2132-2137. www.TheOncologist.com